As the world faces the current SARS-CoV-2 pandemic, extensive efforts have been applied
to identify effective therapeutic agents. Convalescent plasma collected from recovered …

Use of convalescent plasma transfusions could be of great value in the current pandemic of
coronavirus disease (COVID-19), given the lack of specific preventative and therapeutic …

Various agents are currently under evaluation as potential treatments in the fight against
coronavirus disease 2019 (COVID-19). Plasma from patients that have overcome COVID-19 …

Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …

Convalescent plasma for the treatment of infectious diseases has been used since the early
20th century and was associated with reduced mortality during the 1918 influenza, 1 2003 …

Infectious diseases remain one of the top 10 global health threats as announced by the
World Health Organization [1]. The emergence of new pathogens for which there is no …

In this issue of Transfusion Medicine Reviews, we are pleased to offer readers an
assessment as of April 2020 of COVID-19 convalescent plasma (CCP) by H Cliff Sullivan …

Background There is currently no treatment known to alter the course of coronavirus disease
2019 (COVID-19). Convalescent plasma has been used to treat a number of infections …

• Previous studies of convalescent plasma in treating other viral diseases have identified
factors to consider when designing treatment protocols, including timing of administration …

Two case series examining the impact of convalescent plasma on patients with COVID-19
suggest some clinical benefit from early administration and modest impact on parameters of …